Sunglow Pharmaceuticalss Profile
Key Indicators
- Authorised Capital ₹ 6.25 Cr
- Paid Up Capital ₹ 6.12 Cr
- Company Age 15 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.40 Cr
- Satisfied Charges ₹ 5.19 Cr
- Revenue Growth 97.18%
- Profit Growth 822.69%
- Ebitda 230.44%
- Net Worth 30.46%
- Total Assets 13.07%
About Sunglow Pharmaceuticalss
Sunglow Pharmaceuticalss Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 January 2010 and has a history of 15 years. Its registered office is in Pondicherry, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.25 Cr and a paid-up capital of Rs 6.12 Cr.
The company currently has active open charges totaling ₹3.40 Cr. The company has closed loans amounting to ₹5.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamaraj and Veerabadran Rajasekaran serve as directors at the Company.
Company Details
- Location
Pondicherry, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232PY2010PTC002407
- Company No.
002407
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2010
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
What products or services does Sunglow Pharmaceuticalss Private Limited offer?
Sunglow Pharmaceuticalss Private Limited offers a wide range of products and services, including Software Development & IT Consultant, Software Development Services, ISO & Quality Management Consultants, Certification Services, Laboratory Equipment, Business Consultant, Business Solution.
Who are the key members and board of directors at Sunglow Pharmaceuticalss?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veerabadran Rajasekaran  | Director | 09-Sep-2013 | Current |
| Kamaraj | Director | 28-May-2010 | Current |
Financial Performance of Sunglow Pharmaceuticalss.
Sunglow Pharmaceuticalss Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 97.18% increase. The company also saw a substantial improvement in profitability, with a 822.69% increase in profit. The company's net worth Soared by an impressive increase of 30.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunglow Pharmaceuticalss?
In 2023, Sunglow Pharmaceuticalss had a promoter holding of 86.97% and a public holding of 13.03%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunglow Lifescience Private LimitedKamaraj and Veerabadran Rajasekaran are mutual person
Relimed Pharmaceuticals Private LimitedKamaraj and Veerabadran Rajasekaran are mutual person
- Adiramedica Private Limited
Veerabadran Rajasekaran is a mutual person
Charges (Loans)
₹3.40 Cr
₹5.19 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 3.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2017 | Axis Bank Limited | ₹3.40 Cr | Open |
| 30 Jul 2020 | Axis Bank Limited | ₹6.00 M | Satisfied |
| 28 Nov 2013 | Hdfc Bank Limited | ₹3.34 Cr | Satisfied |
| 21 Mar 2011 | Uco Bank | ₹1.25 Cr | Satisfied |
How Many Employees Work at Sunglow Pharmaceuticalss?
Sunglow Pharmaceuticalss has a workforce of 50 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunglow Pharmaceuticalss, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunglow Pharmaceuticalss's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
